Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

New insights into epithelial-mesenchymal transition in kidney fibrosis.

Liu Y.

J Am Soc Nephrol. 2010 Feb;21(2):212-22. doi: 10.1681/ASN.2008121226. Epub 2009 Dec 17. Review.

2.

beta1 integrin/FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival.

Saleem S, Li J, Yee SP, Fellows GF, Goodyer CG, Wang R.

J Pathol. 2009 Oct;219(2):182-92. doi: 10.1002/path.2577.

PMID:
19544355
3.

Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis.

Li Y, Tan X, Dai C, Stolz DB, Wang D, Liu Y.

J Am Soc Nephrol. 2009 Sep;20(9):1907-18. doi: 10.1681/ASN.2008090930. Epub 2009 Jun 18.

4.

Fibroblast activation and myofibroblast generation in obstructive nephropathy.

Grande MT, López-Novoa JM.

Nat Rev Nephrol. 2009 Jun;5(6):319-28. doi: 10.1038/nrneph.2009.74. Review.

PMID:
19474827
5.

c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry.

Morrish F, Isern N, Sadilek M, Jeffrey M, Hockenbery DM.

Oncogene. 2009 Jul 9;28(27):2485-91. doi: 10.1038/onc.2009.112. Epub 2009 May 18.

6.

Renal tubulointerstitial fibrosis: common but never simple.

Hewitson TD.

Am J Physiol Renal Physiol. 2009 Jun;296(6):F1239-44. doi: 10.1152/ajprenal.90521.2008. Epub 2009 Jan 14. Review.

7.

Cell cycle machinery: links with genesis and treatment of breast cancer.

Butt AJ, Caldon CE, McNeil CM, Swarbrick A, Musgrove EA, Sutherland RL.

Adv Exp Med Biol. 2008;630:189-205. Review.

PMID:
18637492
8.

Novel actions of tissue-type plasminogen activator in chronic kidney disease.

Hu K, Mars WM, Liu Y.

Front Biosci. 2008 May 1;13:5174-86. Review.

9.

tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis.

Hu K, Lin L, Tan X, Yang J, Bu G, Mars WM, Liu Y.

J Am Soc Nephrol. 2008 Mar;19(3):503-14. doi: 10.1681/ASN.2007030300. Epub 2008 Jan 16.

11.

The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development.

Montel V, Gaultier A, Lester RD, Campana WM, Gonias SL.

Cancer Res. 2007 Oct 15;67(20):9817-24.

12.

Cyclin degradation for cancer therapy and chemoprevention.

Freemantle SJ, Liu X, Feng Q, Galimberti F, Blumen S, Sekula D, Kitareewan S, Dragnev KH, Dmitrovsky E.

J Cell Biochem. 2007 Nov 1;102(4):869-77. Review.

PMID:
17868090
13.

Breast cancer cell proliferation is inhibited by BAD: regulation of cyclin D1.

Fernando R, Foster JS, Bible A, Ström A, Pestell RG, Rao M, Saxton A, Baek SJ, Yamaguchi K, Donnell R, Cekanova M, Wimalasena J.

J Biol Chem. 2007 Sep 28;282(39):28864-73. Epub 2007 Aug 1.

14.

TGF-beta in renal injury and disease.

Böttinger EP.

Semin Nephrol. 2007 May;27(3):309-20. Review.

PMID:
17533008
16.

Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.

Hurtado M, Lozano JJ, Castellanos E, López-Fernández LA, Harshman K, Martínez-A C, Ortiz AR, Thomson TM, Paciucci R.

Gut. 2007 Sep;56(9):1266-74. Epub 2007 Apr 23.

17.

Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.

Toualbi K, Güller MC, Mauriz JL, Labalette C, Buendia MA, Mauviel A, Bernuau D.

Oncogene. 2007 May 24;26(24):3492-502. Epub 2006 Dec 4.

PMID:
17146436
18.

Renal fibroblasts and myofibroblasts in chronic kidney disease.

Strutz F, Zeisberg M.

J Am Soc Nephrol. 2006 Nov;17(11):2992-8. Epub 2006 Oct 11. Review. No abstract available.

19.

Disruption of tissue plasminogen activator gene reduces macrophage migration.

Ling C, Zou T, Hsiao Y, Tao X, Chen ZL, Strickland S, Song H.

Biochem Biophys Res Commun. 2006 Oct 27;349(3):906-12. Epub 2006 Aug 28.

PMID:
16978586
20.

Mechanisms of disease: Fibroblasts--a new look at an old problem.

Neilson EG.

Nat Clin Pract Nephrol. 2006 Feb;2(2):101-8. Review.

PMID:
16932401

Supplemental Content

Support Center